Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...

“My life is unfortunately never going to be what it was,” said Emily McAllister ...

Researchers developed a topical gene therapy that corrects disease-causing mutations in human skin models using lipid ...

Please provide your email address to receive an email when new articles are posted on . The researchers were tasked with helping a patient who had a novel form of recalcitrant erythroderma. Using a ...

This article is part of Nature Outlook: Skin, an editorially independent supplement produced with financial support from LEO Pharma. About this content. KaDee Troop is the mother of seven adopted ...

Transthyretin amyloidosis (ATTR) is a rare, progressive and highly aggressive degenerative disease. It is caused by the ...

Gene-editing techniques such as CRISPR have enabled new treatments for previously incurable diseases. Researchers at the ...

Steven Daniel Daveluy, MD, FAAD, discussed how artificial intelligence (AI) can leverage extensive patient data and guide dermatologists to improve early diagnosis and treatment of rare dermatological ...

Quoin Pharmaceuticals Ltd. has filed a U.S. patent application for new topical formulations aimed at treating several skin diseases, specifically Netherton Syndrome (NS) and Peeling Skin Syndrome. The ...

After a poor showing of its COVID med vilobelimab in a rare skin disorder trial, German drugmaker InflaRx is going back to the drawing board. The independent data monitoring committee assessing a ...

A net-like blue or purple pattern on the skin may signal blocked arteries, experts warn. Learn what livedo reticularis is, ...